Resilient Biotics
Research Triangle Park, US · Founded 2016 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
RG
Rachelle GalvinExecutive Officer, Director
CB
Christopher BelnapExecutive Officer, Director
GW
Greg WernerExecutive Officer, Director
DL
Drew LanzaDirector
EE
Eric EasonDirector
JP
John PeryamDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$3.9MraisedDec 2024 · 6 investors · BiotechnologyRule 506(b)
▶$3.9MraisedDec 2024 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric EasonDirector
- John PeryamDirector
- Rachelle GalvinExecutive Officer, Director
- Drew LanzaDirector
- Christopher BelnapExecutive Officer, Director
- Offering amount
- $4.6M
- Amount sold
- $3.9M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.2MraisedDec 2020 · 18 investors · BiotechnologyRule 506(b)
▶$7.2MraisedDec 2020 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher BelnapExecutive Officer, Director
- Eric EasonDirector
- John PeryamDirector
- Greg WernerExecutive Officer, Director
- Offering amount
- $7.2M
- Amount sold
- $7.2M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.